Prevention of Myc‐Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane
Molecular Carcinogenesis · 2026-09 · 65 (9) · 1052-1062
DOI: 10.1002/mc.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 18.06.2026. Verfasst von Krishna B Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Isothiocyanates, Prostatic Neoplasms, Anticarcinogenic Agents, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute at the National Institutes of Health.
Abstract (Originalsprache)
Prevention is desirable to reduce suffering and death from prostate cancer. However, a clinical‐grade intervention for the prevention of this malignancy is still lacking. This study was undertaken to determine the feasibility of prostate cancer prevention by broccoli constituent sulforaphane (SFN) because epidemiological studies have suggested an inverse association between intake of broccoli and the risk of prostate cancer. Oral administration of 1 mg SFN/mouse (three times/week) to 5‐week‐old male Hi‐Myc transgenic mice for 5 weeks decreased the incidence of prostatic adenocarcinoma in situ by about 54% without causing weight loss or any other side effects. Existing literature strongly implicates fatty acid synthesis in prostate cancer progression. Therefore, we determined the effect of SFN treatment on fatty acid synthesis. Prostate cancer prevention by SFN in Hi‐Myc mice was accompanied by a decrease in: (a) the uptake of 11 C‐acetate in the prostate of live mice; (b) plasma levels of fatty acid synthesis intermediates acetyl‐CoA and malonyl‐CoA; (c) circulating levels of total free fatty acids (TFFA); (d) downregulation of fatty acid synthesis enzyme proteins acetyl‐CoA carboxylase 1 and fatty acid synthase; and (e) plasma levels of interkeukin‐10 and interleukin‐12. Because prostate cancer in Hi‐Myc mice is driven by Myc, we determined the effect of overexpression of c‐Myc in 22Rv1 cells on TFFA level. Overexpression of c‐Myc conferred partial protection against TFFA suppression by SFN treatment. In summary, this study reveals that SFN administration prevents prostate cancer development in Hi‐Myc mice by suppressing fatty acid synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Division of Health Services Research, Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute at the National Institutes of Health
Zitieren
APA
Singh, K. B., Hahm, E. R., Jacobs, B. L., & Singh, S. V. (2026). Prevention of Myc‐Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane. Molecular Carcinogenesis, 65(9), 1052-1062. https://doi.org/10.1002/mc.70139
Vancouver
Singh KB, Hahm ER, Jacobs BL, Singh SV. Prevention of Myc‐Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane. Molecular Carcinogenesis. 2026;65(9):1052-1062. doi:10.1002/mc.70139
BibTeX
@article{Singh2026,
author = {Singh, Krishna B and Hahm, Eun-Ryeong and Jacobs, Bruce L and Singh, Shivendra V},
title = {Prevention of Myc‐Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane},
journal = {Molecular Carcinogenesis},
year = {2026},
volume = {65},
number = {9},
pages = {1052--1062},
doi = {10.1002/mc.70139}
}
EUVIMED